Literature DB >> 35469116

Imaging subtle leaks in the blood-brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions.

Axel Montagne1,2, Samuel R Barnes3, Daniel A Nation4,5, Kassandra Kisler6, Arthur W Toga7,8, Berislav V Zlokovic9,10.   

Abstract

Recent studies using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with gadolinium-based contrast agents (GBCA) have demonstrated subtle blood-brain barrier (BBB) leaks in the human brain during normal aging, in individuals with age-related cognitive dysfunction, genetic risk for Alzheimer's disease (AD), mild cognitive impairment, early AD, cerebral small vessel disease (SVD), and other neurodegenerative disorders. In these neurological conditions, the BBB leaks, quantified by the unidirectional BBB GBCA tracer's constant Ktrans maps, are typically orders of magnitude lower than in brain tumors, after stroke and/or during relapsing episodes of multiple sclerosis. This puts extra challenges for the DCE-MRI technique by pushing calculations towards its lower limits of detectability. In addition, presently, there are no standardized multivendor protocols or evidence of repeatability and reproducibility. Nevertheless, subtle BBB leaks may critically contribute to the pathophysiology of cognitive impairment and dementia associated with AD or SVD, and therefore, efforts to improve sensitivity of detection, reliability, and reproducibility are warranted. A larger number of participants scanned by different MR scanners at different clinical sites are sometimes required to detect differences in BBB integrity between control and at-risk groups, which impose additional challenges. Here, we focus on these new challenges and propose some approaches to normalize and harmonize DCE data between different scanners. In brief, we recommend specific regions to be used for the tracer's vascular input function and DCE data processing and how to find and correct negative Ktrans values that are physiologically impossible. We hope this information will prove helpful to new investigators wishing to study subtle BBB damage in neurovascular and neurodegenerative conditions and in the aging human brain.
© 2022. The Author(s), under exclusive licence to American Aging Association.

Entities:  

Keywords:  Aging population; Alzheimer’s disease; Blood–brain barrier permeability; Cognitive impairment; Dementia; Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI); Small vessel disease

Mesh:

Substances:

Year:  2022        PMID: 35469116      PMCID: PMC9213625          DOI: 10.1007/s11357-022-00571-x

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.581


  63 in total

Review 1.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

2.  Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease.

Authors:  Giuseppe Barisano; Axel Montagne; Kassandra Kisler; Julie A Schneider; Joanna M Wardlaw; Berislav V Zlokovic
Journal:  Nat Cardiovasc Res       Date:  2022-02-07

Review 3.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 4.  Blood-Brain Barrier: From Physiology to Disease and Back.

Authors:  Melanie D Sweeney; Zhen Zhao; Axel Montagne; Amy R Nelson; Berislav V Zlokovic
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 5.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 6.  Recommendations of the Alzheimer's disease-related dementias conference.

Authors:  Thomas J Montine; Walter J Koroshetz; Debra Babcock; Dennis W Dickson; Wendy R Galpern; M Maria Glymour; Steven M Greenberg; Michael L Hutton; David S Knopman; Andrey N Kuzmichev; Jennifer J Manly; Karen S Marder; Bruce L Miller; Creighton H Phelps; William W Seeley; Beth-Anne Sieber; Nina B Silverberg; Margaret Sutherland; Christine L Torborg; Salina P Waddy; Berislav V Zlokovic; Roderick A Corriveau
Journal:  Neurology       Date:  2014-07-30       Impact factor: 9.910

Review 7.  The role of brain vasculature in neurodegenerative disorders.

Authors:  Melanie D Sweeney; Kassandra Kisler; Axel Montagne; Arthur W Toga; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

8.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.

Authors:  Y Iturria-Medina; R C Sotero; P J Toussaint; J M Mateos-Pérez; A C Evans
Journal:  Nat Commun       Date:  2016-06-21       Impact factor: 14.919

Review 9.  Alzheimer's Disease and Vascular Aging: JACC Focus Seminar.

Authors:  Marta Cortes-Canteli; Costantino Iadecola
Journal:  J Am Coll Cardiol       Date:  2020-03-03       Impact factor: 24.094

10.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more
  1 in total

1.  Exploration of acupuncture therapy in the treatment of mild cognitive impairment based on the brain-gut axis theory.

Authors:  Yuanyuan Jin; Fen Hu; Jianfang Zhu
Journal:  Front Hum Neurosci       Date:  2022-09-20       Impact factor: 3.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.